# An Open Multiple Dose Titration Study In Patients With Pulmonary Hypertension

> **NCT00454558** · PHASE2 · COMPLETED · sponsor: **Bayer** · enrollment: 75 (actual)

## Conditions studied

- Hypertension, Pulmonary

## Interventions

- **DRUG:** Riociguat (Adempas, BAY63-2521)

## Key facts

- **NCT ID:** NCT00454558
- **Lead sponsor:** Bayer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-01
- **Primary completion:** 2014-07
- **Final completion:** 2014-09
- **Target enrollment:** 75 (ACTUAL)
- **Last updated:** 2015-10-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00454558

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00454558, "An Open Multiple Dose Titration Study In Patients With Pulmonary Hypertension". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00454558. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*